• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination.多黏菌素和替加环素对多重耐药鲍曼不动杆菌生物膜的影响:联合应用的优缺点。
Sci Rep. 2021 Jun 3;11(1):11700. doi: 10.1038/s41598-021-90732-3.
2
Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.多黏菌素与利福平、美罗培南和替加环素联合应用对碳青霉烯类耐药肺炎克雷伯菌生物膜的剂量依赖性协同作用。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02357-18. Print 2019 Mar.
3
Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.亚最低抑菌浓度的多粘菌素 B 和多粘菌素促进鲍曼不动杆菌生物膜形成。
PLoS One. 2018 Mar 19;13(3):e0194556. doi: 10.1371/journal.pone.0194556. eCollection 2018.
4
Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.美罗培南、亚胺培南、舒巴坦、黏菌素和替加环素对生物膜包裹的鲍曼不动杆菌及生物膜结构的单独或联合作用
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4670-6. doi: 10.1128/AAC.00551-16. Print 2016 Aug.
5
Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.左氧氟沙星联合黏菌素对鲍曼不动杆菌的活性:体外和大蜡螟模型。
J Microbiol Immunol Infect. 2017 Dec;50(6):821-830. doi: 10.1016/j.jmii.2015.10.010. Epub 2015 Nov 26.
6
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.黏菌素、替加环素和多尼培南抗生素组合对广泛耐药和多重耐药鲍曼不动杆菌的体外相互作用
Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124.
7
Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.生物膜形成缺陷的耐黏菌素鲍曼不动杆菌临床菌株
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1892-5. doi: 10.1128/AAC.02518-15.
8
Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.蜂毒素与亚胺培南和黏菌素联合对鲍曼不动杆菌多药耐药强生物膜生成株生物膜抑制的高度协同作用。
Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):443-454. doi: 10.1007/s10096-018-3189-7. Epub 2018 Jan 20.
9
Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.在重症环境下,基于替加环素与基于黏菌素的治疗方案对多重耐药鲍曼不动杆菌所致肺炎的治疗效果:一项配对队列分析
BMC Infect Dis. 2014 Feb 24;14:102. doi: 10.1186/1471-2334-14-102.
10
Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages.耐多药鲍曼不动杆菌能抵抗活性氧,并且能在巨噬细胞内存活。
Sci Rep. 2019 Nov 25;9(1):17462. doi: 10.1038/s41598-019-53846-3.

引用本文的文献

1
Cefmetazole, flomoxef, and meropenem are effective against planktonic cells but not biofilms of extended-spectrum β-lactamase-producing Escherichia coli.头孢美唑、氟氧头孢和美罗培南对产超广谱β-内酰胺酶大肠埃希菌的浮游细胞有效,但对其生物膜无效。
BMC Microbiol. 2025 Jul 2;25(1):387. doi: 10.1186/s12866-025-04088-z.
2
Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review.超越抗生素:探索现代对抗细菌耐药性的多方面方法:全面综述
Front Cell Infect Microbiol. 2025 Mar 18;15:1493915. doi: 10.3389/fcimb.2025.1493915. eCollection 2025.
3
Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice.杀菌性与抑菌性抗菌药物:临床意义、差异及临床实践中的协同潜力
J Antimicrob Chemother. 2025 Jan 3;80(1):1-17. doi: 10.1093/jac/dkae380.
4
Resensitization to colistin results in rapid and stable recovery of adherence, serum resistance and ompW in Acinetobacter baumannii.对黏菌素的再致敏导致鲍曼不动杆菌的黏附、血清抗性和 ompW 迅速而稳定的恢复。
PLoS One. 2024 Aug 28;19(8):e0309307. doi: 10.1371/journal.pone.0309307. eCollection 2024.
5
Analysis of carbapenem-resistant carbapenemase gene distribution and biofilm formation.耐碳青霉烯类碳青霉烯酶基因分布及生物膜形成分析
Int J Mol Epidemiol Genet. 2024 Feb 15;15(1):1-11. doi: 10.62347/KBSB9946. eCollection 2024.
6
The use of combination therapy for the improvement of colistin activity against bacterial biofilm.联合治疗提高黏菌素对细菌生物膜活性的应用。
Braz J Microbiol. 2024 Mar;55(1):411-427. doi: 10.1007/s42770-023-01189-7. Epub 2023 Nov 30.
7
in the critically ill: complex infections get complicated.在危重症患者中:复杂感染会变得更加复杂。
Front Microbiol. 2023 Jun 22;14:1196774. doi: 10.3389/fmicb.2023.1196774. eCollection 2023.
8
Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.鲍曼不动杆菌分离株对替加环素和多黏菌素的多重异质性耐药及其对联合抗生素治疗的影响。
J Biomed Sci. 2023 Jun 7;30(1):37. doi: 10.1186/s12929-023-00914-6.
9
Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant and : A Propensity Score-Matched Cohort Study.静脉注射多粘菌素B作为大剂量替加环素的辅助治疗用于耐碳青霉烯类的医院获得性肺炎的治疗:一项倾向评分匹配队列研究
Antibiotics (Basel). 2023 Jan 30;12(2):273. doi: 10.3390/antibiotics12020273.
10
Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis.静脉注射多黏菌素单药治疗与联合治疗的最佳给药间隔:一项系统评价与荟萃分析。
Eur J Transl Myol. 2022 Oct 27;32(4):10833. doi: 10.4081/ejtm.2022.10833.

本文引用的文献

1
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review.替加环素的抗菌活性、临床疗效以及耐药机制和流行病学:叙述性综述。
Eur J Clin Microbiol Infect Dis. 2022 Jul;41(7):1003-1022. doi: 10.1007/s10096-020-04121-1. Epub 2021 Jan 5.
2
A rapid and simple measurement method for biofilm formation inhibitory activity using 96-pin microtiter plate lids.使用 96 孔微量滴定板盖快速简便地测量生物膜形成抑制活性的方法。
World J Microbiol Biotechnol. 2020 Nov 26;36(12):189. doi: 10.1007/s11274-020-02964-6.
3
The Outer Membrane Proteins OmpA, CarO, and OprD of Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen.[细菌名称]的外膜蛋白OmpA、CarO和OprD在促进其成为一种强大的人类病原体方面提供了双重防御。
Front Microbiol. 2020 Oct 6;11:589234. doi: 10.3389/fmicb.2020.589234. eCollection 2020.
4
Insights Into Mechanisms of Biofilm Formation in and Implications for Uropathogenesis.对生物膜形成机制的洞察及其对尿路发病机制的影响。
Front Cell Infect Microbiol. 2020 May 29;10:253. doi: 10.3389/fcimb.2020.00253. eCollection 2020.
5
Insights into : A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen.深入剖析:一种威胁性医院病原体的微生物学、毒力和耐药特性综述
Antibiotics (Basel). 2020 Mar 12;9(3):119. doi: 10.3390/antibiotics9030119.
6
Genome and Transcriptome Analysis of A. baumannii's "Transient" Increase in Drug Resistance under Tigecycline Pressure.鲍曼不动杆菌在替加环素压力下“一过性”耐药增加的基因组和转录组分析。
J Glob Antimicrob Resist. 2020 Sep;22:219-225. doi: 10.1016/j.jgar.2020.02.003. Epub 2020 Feb 19.
7
Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes.质粒增强了尿路感染病原体鲍曼不动杆菌染色体基因的尿路定植。
Nat Commun. 2019 Jun 24;10(1):2763. doi: 10.1038/s41467-019-10706-y.
8
Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by .亚抑菌浓度的美罗培南和替加环素对由……参与生物膜形成的菌毛、外排泵及毒力因子调控基因表达的影响 。 需注意,原文句末“by.”后面似乎缺少具体内容。
Infect Drug Resist. 2019 May 7;12:1099-1111. doi: 10.2147/IDR.S199993. eCollection 2019.
9
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.抗菌药物耐药时代对抗ESKAPE病原体的新兴策略:综述
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.
10
Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.亚最低抑菌浓度的多粘菌素 B 和多粘菌素促进鲍曼不动杆菌生物膜形成。
PLoS One. 2018 Mar 19;13(3):e0194556. doi: 10.1371/journal.pone.0194556. eCollection 2018.

多黏菌素和替加环素对多重耐药鲍曼不动杆菌生物膜的影响:联合应用的优缺点。

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination.

机构信息

Department of Microbiology and Immunology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.

出版信息

Sci Rep. 2021 Jun 3;11(1):11700. doi: 10.1038/s41598-021-90732-3.

DOI:10.1038/s41598-021-90732-3
PMID:34083569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8175759/
Abstract

We investigated the antimicrobial effects of colistin (CST) and tigecycline (TGC), either alone or in combination, on biofilm-dispersed and biofilm-embedded multidrug-resistant Acinetobacter baumannii (MDRAB) strains R1 and R2. The bacterial growth of biofilm-dispersed MDRAB was inhibited by CST or TGC. However, the inhibitory effects were attenuated by a combination of CST and low concentrations of TGC. The bactericidal effects of CST, but not TGC, were observed on biofilm-dispersed MDRAB. Notably, the bactericidal effects increased with a combination of CST and high concentrations of TGC, whereas they were attenuated with the combination of CST and low concentrations of TGC. Although biofilm formation by MDRAB decreased with increasing concentrations of CST or TGC, there was no complete disruption of the biofilms. Additionally, the biofilms increased with a combination of 1-2 μg/mL CST and TGC at 2 μg/mL and 2-4 μg/mL for strains R1 and R2, respectively. Biofilm-embedded MDRAB was eradicated with CST, but not TGC. Notably, the eradication effects increased with a combination of CST and high concentrations of TGC, whereas attenuation happened with the combination of CST and low concentrations of TGC. These results provide information on the combined effects of CST and TGC in the treatment of biofilm-associated MDRAB infection.

摘要

我们研究了多粘菌素(CST)和替加环素(TGC)单独或联合应用对生物膜分散和嵌入的多药耐药鲍曼不动杆菌(MDRAB)菌株 R1 和 R2 的抗菌作用。CST 或 TGC 抑制生物膜分散的 MDRAB 的细菌生长。然而,CST 和低浓度 TGC 的联合使用减弱了抑制作用。CST 对生物膜分散的 MDRAB 具有杀菌作用,但 TGC 没有。值得注意的是,CST 和高浓度 TGC 的联合使用增加了杀菌作用,而 CST 和低浓度 TGC 的联合使用则减弱了杀菌作用。尽管 CST 或 TGC 浓度的增加降低了 MDRAB 的生物膜形成,但生物膜并没有完全被破坏。此外,生物膜在 CST 与 TGC 的联合作用下增加,对于菌株 R1 和 R2,分别在 CST 1-2μg/mL 和 TGC 2-4μg/mL 时增加。CST 可以根除生物膜嵌入的 MDRAB,但 TGC 不能。值得注意的是,CST 和高浓度 TGC 的联合使用增加了根除作用,而 CST 和低浓度 TGC 的联合使用则减弱了根除作用。这些结果提供了 CST 和 TGC 联合应用治疗生物膜相关 MDRAB 感染的信息。